GC36305
Imrecoxib
Also known as 4-(4-methylphenyl)-3-(4-methylsulfonylphenyl)-1-propyl-2H-pyrrol-5-one
Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 (COX-2) inhibitor with an IC50 value of 18 nM, it also inhibits COX1- activity with an IC50 value of 115 nM
ChemicalCAS395683-14-4MW369.48FormulaC21H23NO3S
- CAS number
- 395683-14-4
- Molecular weight
- 369.48
- Formula
- C21H23NO3S
- Solubility
- DMSO： 100 mg/mL (270·65 mM)
- InChIKey
- AXMZZGKKZDJGAZ-UHFFFAOYSA-N
- Catalogue number
- GC36305
- Brand
- GLPBIO
Computed properties PubChem CID 11682175 · XLogP 3.1 · TPSA 62.8 Ų · H-bond donors 0
- XLogP
- 3.1
- TPSA
- 62.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 3
- Rotatable bonds
- 5
- Heavy atoms
- 26
SMILES CCCN1CC(=C(C1=O)C2=CC=C(C=C2)C)C3=CC=C(C=C3)S(=O)(=O)C
Computed descriptors from PubChem (CID 11682175), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il